BATF3
Basic leucine zipper transcriptional factor ATF-like 3
Also known as: BATF3_HUMAN, JDP1, JUNDM1, SNFT
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NR55
- Gene
- BATF3
- Ensembl
- ENSG00000123685
- Chromosome
- 1
- Canonical length
- 127 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
This gene encodes a member of the basic leucine zipper protein family. The encoded protein functions as a transcriptional repressor when heterodimerizing with JUN. The protein may play a role in repression of interleukin-2 and matrix metalloproteinase-1 transcription.[provided by RefSeq, Feb 2009]
Canonical amino-acid sequenceUniProt
127 residues, UniProt reviewed canonical sequence.
>Q9NR55|BATF3
1 MSQGLPAAGS VLQRSVAAPG NQPQPQPQQQ SPEDDDRKVR RREKNRVAAQ RSRKKQTQKA
61 DKLHEEYESL EQENTMLRRE IGKLTEELKH LTEALKEHEK MCPLLLCPMN FVPVPPRPDP
121 VAGCLPRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BATF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 25 nTPM
- spleen: 11 nTPM
- basal ganglia: 10 nTPM
- lung: 8.8 nTPM
- adipose tissue: 8.5 nTPM
- cerebral cortex: 6.3 nTPM
Single-cell type
- cdc: 74 nCPM
- extravillous trophoblasts: 58 nCPM
- microglia: 26 nCPM
- pericytes: 25 nCPM
- macrophages: 19 nCPM
- vascular smooth muscle cells: 19 nCPM
Immune cell
- non-classical monocyte: 100 nTPM
- intermediate monocyte: 66 nTPM
- myeloid DC: 55 nTPM
- classical monocyte: 14 nTPM
- total PBMC: 8.8 nTPM
- neutrophil: 2.2 nTPM
Brain region
- choroid plexus: 17 nTPM
- basal ganglia: 4.2 nTPM
- cerebral cortex: 3.2 nTPM
- spinal cord: 3 nTPM
- hippocampal formation: 2.5 nTPM
- white matter: 2.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.27
- gnomAD pLI
- 0.03
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dendritic cell differentiation
- integrated stress response signaling
- myeloid dendritic cell differentiation
- negative regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- response to virus
Molecular functions
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BATF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BATF3 as an antibody target. Whether an autoantibody or antibody against BATF3 could matter depends on whether native BATF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BATF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BATF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...